Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Disterer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon-skipping to induce gene knockdownPetra Disterer, Bernard Khoo
The Journal of Gene Medicine|January 21, 2009
Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editingIoannis Papaioannou, Petra Disterer, James S Owen
The Journal of Biological Chemistry|May 8, 2004
Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob diseaseAbdessamad Tahiri-Alaoui, Andrew C Gill, Petra Disterer, et al.
Journal of Virology|August 28, 2003
Multigene RNA vector based on coronavirus transcriptionVolker Thiel, Nadja Karl, Barbara Schelle, et al.
The Journal of Gene Medicine|January 10, 2012
Oligonucleotide-mediated gene editing is underestimated in cells expressing mutated green fluorescent protein and is positively associated with target protein expressionPetra Disterer, Ioannis Papaioannou, Vanessa C Evans, et al.
FEBS Letters|May 3, 2005
The presence of valine at residue 129 in human prion protein accelerates amyloid formationIlia Baskakov, Petra Disterer, Leonid Breydo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivoPetra Disterer, Raya Al-Shawi, Stephan Ellmerich, et al.
Human Gene Therapy|May 16, 2014
Development of therapeutic splice-switching oligonucleotidesPetra Disterer, Adrianna Kryczka, Yuqi Liu, et al.
The Journal of Biological Chemistry|August 7, 2003
Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversionAlexandre Rhie, Louise Kirby, Natalie Sayer, et al.
Molecular and Cellular Endocrinology|September 17, 2014
Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulationAikaterini Theodoraki, Youli Hu, Subathra Poopalasundaram, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Antisense-mediated exon-skipping to induce gene knockdownPetra Disterer, Bernard Khoo
The Journal of Gene Medicine|January 21, 2009
Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editingIoannis Papaioannou, Petra Disterer, James S Owen
The Journal of Biological Chemistry|May 8, 2004
Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob diseaseAbdessamad Tahiri-Alaoui, Andrew C Gill, Petra Disterer, et al.
Journal of Virology|August 28, 2003
Multigene RNA vector based on coronavirus transcriptionVolker Thiel, Nadja Karl, Barbara Schelle, et al.
The Journal of Gene Medicine|January 10, 2012
Oligonucleotide-mediated gene editing is underestimated in cells expressing mutated green fluorescent protein and is positively associated with target protein expressionPetra Disterer, Ioannis Papaioannou, Vanessa C Evans, et al.
FEBS Letters|May 3, 2005
The presence of valine at residue 129 in human prion protein accelerates amyloid formationIlia Baskakov, Petra Disterer, Leonid Breydo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivoPetra Disterer, Raya Al-Shawi, Stephan Ellmerich, et al.
Human Gene Therapy|May 16, 2014
Development of therapeutic splice-switching oligonucleotidesPetra Disterer, Adrianna Kryczka, Yuqi Liu, et al.
The Journal of Biological Chemistry|August 7, 2003
Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversionAlexandre Rhie, Louise Kirby, Natalie Sayer, et al.
Molecular and Cellular Endocrinology|September 17, 2014
Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulationAikaterini Theodoraki, Youli Hu, Subathra Poopalasundaram, et al.
Pageof 2